-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Orchestra BioMed Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
- Orchestra BioMed Holdings, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$16.9M, a 30.1% decline year-over-year.
- Orchestra BioMed Holdings, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$58.3M, a 31.3% decline year-over-year.
- Orchestra BioMed Holdings, Inc. annual Operating Income (Loss) for 2023 was -$51.5M, a 57.7% decline from 2022.
- Orchestra BioMed Holdings, Inc. annual Operating Income (Loss) for 2022 was -$32.7M, a 8173% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)